Page last updated: 2024-09-03

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and thromboplastin

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with thromboplastin in 1 studies

Compound Research Comparison

Studies
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Trials
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Recent Studies (post-2010)
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Studies
(thromboplastin)
Trials
(thromboplastin)
Recent Studies (post-2010) (thromboplastin)
31156410,5402812,126

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishibashi, T; Maruyama, Y; Nagata, K; Nakazato, K; Ohkawara, H; Sakamoto, T; Seino, Y; Teramoto, T; Yokoyama, K1

Other Studies

1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and thromboplastin

ArticleYear
Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes.
    Journal of hypertension, 2001, Volume: 19, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Cells, Cultured; Culture Media; Humans; Monocytes; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Thromboplastin; Tumor Necrosis Factor-alpha

2001